These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 10188142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
    Ciucci A, Palma C, Manzini S, Werge TM.
    Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
    [Abstract] [Full Text] [Related]

  • 3. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
    Geraghty DP, Mussap CJ, Burcher E.
    Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T, Shirahase H, Kanda M, Kunishiro K, Kurahashi K.
    Vascul Pharmacol; 2009 Jan; 51(2-3):147-53. PubMed ID: 19539781
    [Abstract] [Full Text] [Related]

  • 6. Binding of the novel ligand [4,5-3H-Leu10]substance P to high-affinity NK-1 receptors on guinea pig lung membranes: modulation by GTP analogs and sulfhydryl modifying agents.
    Aharony D, Catanese CA, Woodhouse DP.
    J Pharmacol Exp Ther; 1991 Oct; 259(1):146-55. PubMed ID: 1717678
    [Abstract] [Full Text] [Related]

  • 7. Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888.
    Miyayasu K, Mak JC, Nishikawa M, Barnes PJ.
    Mol Pharmacol; 1993 Sep; 44(3):539-44. PubMed ID: 7690449
    [Abstract] [Full Text] [Related]

  • 8. Presence of NK1 receptors on a mucosal-like mast cell line, RBL-2H3 cells.
    Cooke HJ, Fox P, Alferes L, Fox CC, Wolfe SA.
    Can J Physiol Pharmacol; 1998 Feb; 76(2):188-93. PubMed ID: 9635159
    [Abstract] [Full Text] [Related]

  • 9. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C, Tramontana M, Patacchini R, Lecci A, Catalani C, Catalioto RM, Meini S, Valenti C, Altamura M, Giuliani S, Maggi CA.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):140-8. PubMed ID: 16979621
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL, Aharony D, Bialecki RA, Abbott BM, Barthlow HG, Caccese R, Ghanekar S, Lengel D, McCarthy M, Wenrich B, Undem B, Ohnmacht C, Shenvi A, Albert JS, Brown F, Bernstein PR, Russell K.
    J Pharmacol Exp Ther; 2001 Jul 07; 298(1):307-15. PubMed ID: 11408556
    [Abstract] [Full Text] [Related]

  • 11. Neurokinin receptor modulation of respiratory activity in the rabbit.
    Bongianni F, Mutolo D, Cinelli E, Pantaleo T.
    Eur J Neurosci; 2008 Jun 07; 27(12):3233-43. PubMed ID: 18554294
    [Abstract] [Full Text] [Related]

  • 12. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
    Pradier L, Ménager J, Le Guern J, Bock MD, Heuillet E, Fardin V, Garret C, Doble A, Mayaux JF.
    Mol Pharmacol; 1994 Feb 07; 45(2):287-93. PubMed ID: 7509440
    [Abstract] [Full Text] [Related]

  • 13. High affinity binding sites for [3H]substance P in urinary bladders of cats with interstitial cystitis.
    Buffington CA, Wolfe SA.
    J Urol; 1998 Aug 07; 160(2):605-11. PubMed ID: 9679937
    [Abstract] [Full Text] [Related]

  • 14. Canine intrinsic cardiac neurons involved in cardiac regulation possess NK1, NK2, and NK3 receptors.
    Thompson GW, Hoover DB, Ardell JL, Armour JA.
    Am J Physiol; 1998 Nov 07; 275(5):R1683-9. PubMed ID: 9791091
    [Abstract] [Full Text] [Related]

  • 15. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase.
    Jeurissen F, Kavelaars A, Korstjens M, Broeke D, Franklin RA, Gelfand EW, Heijnen CJ.
    J Immunol; 1994 Mar 15; 152(6):2987-94. PubMed ID: 7511635
    [Abstract] [Full Text] [Related]

  • 16. Effect of neurokinins on canine prostate cell physiology.
    Walden PD, Marinese D, Srinivasan D, Tzoumaka E, Syyong HT, Ford AP, Bhattacharya A.
    Prostate; 2005 Jun 01; 63(4):358-68. PubMed ID: 15611996
    [Abstract] [Full Text] [Related]

  • 17. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1.
    Nakamura M, Ofuji K, Chikama T, Nishida T.
    Br J Pharmacol; 1997 Feb 01; 120(4):547-52. PubMed ID: 9051288
    [Abstract] [Full Text] [Related]

  • 18. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M.
    Neuro Endocrinol Lett; 2005 Aug 01; 26(4):367-72. PubMed ID: 16136007
    [Abstract] [Full Text] [Related]

  • 19. [3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain.
    Griffante C, Carletti R, Andreetta F, Corsi M.
    Br J Pharmacol; 2006 May 01; 148(1):39-45. PubMed ID: 16501582
    [Abstract] [Full Text] [Related]

  • 20. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M, Boczek-Leszczyk E.
    J Physiol Pharmacol; 2008 Sep 01; 59(3):553-62. PubMed ID: 18953097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.